Boston Scientific Sends Two Advisories To Doctors About Guidant Products
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific has sent two safety advisories to physicians, the company announced May 15. The letters are the first consequence of an ongoing review of the cardiac rhythm management devices it acquired through its recent purchase of Guidant